| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6116782 | Human Immunology | 2013 | 7 Pages |
Abstract
These results point to an important role for activating killer immunoglobulin-like receptors in the control of hepatitis C virus infection and progression to hepatocellular carcinoma. In clinical practice, assessment of killer immunoglobulin-like receptor and hepatitis C viral genotype combinations should allow for more accurate monitoring of patients with chronic hepatitis C virus infection.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Roberto Littera, Fausto Zamboni, Vincenzo Tondolo, Giovanni Fantola, Luchino Chessa, Nicola Orrù, Marco Sanna, Donatella Valentini, Luisella Cappai, Marina Mulargia, Giovanni Caocci, Marcella Arras, Andrea Floris, Sandro Orrù, Giorgio La Nasa,